Cash & equivalents increased 76.3%
Cash & equivalents changed +76.3% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +76.3% from the comparable as-filed period.
Operating income changed -20.6% from the comparable as-filed period.
Operating margin changed -484 basis points from the comparable as-filed period.
Debt changed +15.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Net income changed -16.0% from the comparable as-filed period.
Gross margin changed -118 basis points from the comparable as-filed period.
Gross profit changed -8.1% from the comparable as-filed period.
Revenue changed -6.8% from the comparable as-filed period.
Stock-based compensation changed +9.9% from the comparable as-filed period.
Research & development changed -0.8% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.